Breadcrumb Home Resources and Information Physicians and Scientists Resource Hub Characterizing Bleeding Adverse Events Associated With BCR-ABL Tyrosine Kinase Inhibitors: Insights From FAERS Reports Characterizing bleeding adverse events associated with BCR-ABL tyrosine kinase inhibitors: insights from FAERS reports Frontiers in Oncology , Oct 2026 Liang R et al. Front Oncol, September 2026 Link to full abstract Share Tweet Share Share